UBS ASSET MANAGEMENT AMERICAS INC - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 219 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$1,685,838
-17.1%
128,298
-17.6%
0.00%0.0%
Q2 2023$2,032,5370.0%155,7500.0%0.00%0.0%
Q1 2023$2,032,537
-19.4%
155,750
+8.9%
0.00%0.0%
Q4 2022$2,521,850
-99.9%
142,962
-6.0%
0.00%0.0%
Q3 2022$2,316,878,000
-11.8%
152,126
-14.1%
0.00%0.0%
Q2 2022$2,627,045,000
-27.5%
177,144
+10.1%
0.00%
-50.0%
Q1 2022$3,624,120,000
+7.2%
160,929
-12.2%
0.00%
+100.0%
Q4 2021$3,380,465,000
+16.6%
183,223
-15.5%
0.00%0.0%
Q3 2021$2,898,297,000
-28.8%
216,776
-1.4%
0.00%
-50.0%
Q2 2021$4,067,960,000
+42.4%
219,771
+15.5%
0.00%
+100.0%
Q1 2021$2,857,263,000
-5.5%
190,294
-9.1%
0.00%0.0%
Q4 2020$3,023,505,000
+79.8%
209,384
+1.3%
0.00%0.0%
Q3 2020$1,681,871,000
+26.2%
206,618
+5.0%
0.00%0.0%
Q2 2020$1,332,409,000
-17.0%
196,811
-13.7%
0.00%0.0%
Q1 2020$1,606,197,000
-13.0%
228,153
+21.4%
0.00%0.0%
Q4 2019$1,845,181,000
-7.4%
187,996
+3.6%
0.00%0.0%
Q3 2019$1,993,397,000
+0.3%
181,548
+6.2%
0.00%0.0%
Q2 2019$1,988,404,000
+29.1%
170,972
+5.9%
0.00%0.0%
Q1 2019$1,540,034,000
+24.1%
161,429
+25.4%
0.00%0.0%
Q4 2018$1,240,851,000
-26.9%
128,719
+8.0%
0.00%0.0%
Q3 2018$1,697,688,000
+18.8%
119,1360.0%0.00%0.0%
Q2 2018$1,429,632,000
-8.6%
119,136
-5.9%
0.00%0.0%
Q1 2018$1,563,954,000
-13.7%
126,636
+1.7%
0.00%
-50.0%
Q4 2017$1,812,232,000
+5.4%
124,552
+3.1%
0.00%0.0%
Q3 2017$1,719,012,000
+22.2%
120,802
+9.5%
0.00%
+100.0%
Q2 2017$1,407,184,000
-14.0%
110,281
-14.6%
0.00%
-50.0%
Q1 2017$1,637,064,000
+163116.7%
129,106
+31.6%
0.00%
+100.0%
Q4 2016$1,003,000
-48.3%
98,140
-33.3%
0.00%
-50.0%
Q3 2016$1,939,000
+5.5%
147,240
+1.7%
0.00%0.0%
Q2 2016$1,838,000
-3.9%
144,7610.0%0.00%0.0%
Q1 2016$1,912,000
-30.0%
144,761
-18.5%
0.00%
-33.3%
Q4 2015$2,730,000
+33.0%
177,531
+7.2%
0.00%
+50.0%
Q3 2015$2,053,000
+10.2%
165,575
+21.6%
0.00%0.0%
Q2 2015$1,863,000
+36.5%
136,162
+19.3%
0.00%
+100.0%
Q1 2015$1,365,000
+15.0%
114,162
+22.8%
0.00%0.0%
Q4 2014$1,187,000
-1.9%
92,946
+3.0%
0.00%0.0%
Q3 2014$1,210,000
-16.5%
90,2460.0%0.00%0.0%
Q2 2014$1,449,000
-9.9%
90,246
+1.1%
0.00%
-50.0%
Q1 2014$1,609,000
+41.5%
89,246
+21.3%
0.00%
+100.0%
Q4 2013$1,137,000
-4.1%
73,546
-7.8%
0.00%0.0%
Q3 2013$1,186,000
+12.3%
79,746
-2.2%
0.00%0.0%
Q2 2013$1,056,00081,5460.00%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q4 2020
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders